E-cadherin loss or decrease at the cell membrane of cancer cells has often been associated with worsening histological grade and clinical stage, along with poor prognosis in a variety of tumors, including breast, pancreatic, gastric, and prostate cancer [5,11,12,13,14]. This evidence concerns the gene CDH1 and prostate carcinoma.